Contineum Therapeutics, Inc. Class A Common Stock (CTNM) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 252.96M | 267.92M | 184.93M | 176.84M | 192.13M | 206.39M | 215.14M | 220.32M | 119.71M | 127.71M | 137.53M | 47.24M | 48.39M |
| Cash & Short-Term Investments | 246.33M | 262.9M | 182.41M | 175.48M | 190.71M | 204.76M | 213.91M | 218.65M | 117.91M | 125.19M | 135.13M | 47.24M | 47.24M |
| Cash Only | 20.16M | 75.6M | 42.63M | 20.78M | 22.47M | 21.94M | 40.89M | 77.23M | 16.26M | 15.53M | 17.52M | -47.24M | 5.57M |
| Short-Term Investments | 226.17M | 187.29M | 139.77M | 154.7M | 168.24M | 182.82M | 173.02M | 141.42M | 101.64M | 109.66M | 117.6M | 94.48M | 41.67M |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 6.64M | 5.02M | 2.52M | 1.35M | 1.42M | 1.63M | 1.23M | 1.67M | 1.8M | 2.52M | 2.4M | 0 | 0 |
| Total Non-Current Assets | 8.38M | 8.72M | 5.92M | 6.05M | 6.13M | 6.46M | 891K | 1.03M | 3.85M | 2.68M | 1.52M | -47.24M | 2.24M |
| Property, Plant & Equipment | 8.07M | 8.47M | 5.65M | 5.86M | 6.13M | 6.46M | 888K | 1.03M | 1.23M | 1.4M | 1.36M | 0 | 2.12M |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 312K | 256K | 266K | 186K | 4K | 3K | 3K | 3K | 2.62M | 1.28M | 155K | -47.24M | 129K |
| Total Assets | 261.35M | 276.64M | 190.85M | 182.89M | 198.26M | 212.85M | 216.03M | 221.35M | 123.56M | 130.39M | 139.04M | 0 | 50.64M |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | 31.82% | 29.97% | -11.66% | -17.38% | 60.45% | 63.24% | 55.37% | - | - | 157.5% | - | - | - |
| Total Current Liabilities | 6.66M | 9.74M | 6.36M | 7.21M | 8.95M | 9.97M | 5.81M | 3.74M | 6.23M | 5.48M | 7.44M | 0 | 7.55M |
| Accounts Payable | 1.5M | 1.02M | 786K | 2M | 3.65M | 1.81M | 1.4M | 734K | 570K | 635K | 1.05M | 0 | 430K |
| Days Payables Outstanding | - | - | - | 3.25K | - | - | - | - | - | - | - | - | - |
| Short-Term Debt | 2.3M | 2.34M | 1.48M | 0 | 0 | 0 | 0 | 0 | 474K | 0 | 0 | 0 | 3.95M |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 2.86M | 6.39M | 4.1M | 1.98M | 1.19M | 3.37M | 2.18M | 1.4M | 4.23M | 2.48M | 1.5M | 0 | 0 |
| Current Ratio | 38.00x | 27.50x | 29.07x | 24.51x | 21.47x | 20.69x | 37.06x | 58.92x | 19.20x | 23.29x | 18.50x | - | 6.41x |
| Quick Ratio | 38.00x | 27.50x | 29.07x | 24.51x | 21.47x | 20.69x | 37.06x | 58.92x | 19.20x | 23.29x | 18.50x | - | 6.41x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 4.65M | 5.91M | 4.02M | 4.28M | 4.55M | 4.81M | 0 | 113K | 192.96M | 192.84M | 192.75M | 0 | 3.82M |
| Long-Term Debt | 4.65M | 5.91M | 4.02M | 0 | 0 | 0 | 0 | 0 | 192.62M | 192.62M | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 4.28M | 4.55M | 4.81M | 0 | 113K | 111K | 108K | 0 | 0 | 791K |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 228K | 110K | 192.75M | 0 | 3.02M |
| Total Liabilities | 11.31M | 15.65M | 10.38M | 11.5M | 13.5M | 14.78M | 5.81M | 3.85M | 199.19M | 198.32M | 200.19M | 0 | 11.37M |
| Total Debt | 6.95M | 8.25M | 5.49M | 5.75M | 6M | 6.26M | 611K | 597K | 193.21M | 193.19M | 1.12M | 0 | 5.85M |
| Net Debt | -13.2M | -67.35M | -37.14M | -15.03M | -16.47M | -15.68M | -40.28M | -76.63M | 176.94M | 177.67M | -16.4M | 47.24M | 280K |
| Debt / Equity | 0.03x | 0.03x | 0.03x | 0.03x | 0.03x | 0.03x | 0.00x | 0.00x | - | - | - | - | 0.15x |
| Debt / EBITDA | - | - | - | - | - | 0.07x | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | -0.18x | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | - | -51.43x | -73.38x |
| Total Equity | 250.04M | 260.99M | 180.47M | 171.39M | 184.77M | 198.07M | 210.23M | 217.5M | -75.63M | -67.94M | -61.14M | 39.27M | 39.27M |
| Equity Growth % | 35.33% | 31.77% | -14.16% | -21.2% | 344.31% | 391.55% | 443.82% | - | -292.59% | -273% | - | - | - |
| Book Value per Share | 6.70 | 8.46 | 6.42 | 6.62 | 7.14 | 7.66 | 8.17 | 8.46 | -2.94 | -2.70 | -2.43 | 1.53 | 1.56 |
| Total Shareholders' Equity | 250.04M | 260.99M | 180.47M | 171.39M | 184.77M | 198.07M | 210.23M | 217.5M | -75.63M | -67.94M | -61.14M | 39.27M | 39.27M |
| Common Stock | 37K | 37K | 29K | 26K | 26K | 26K | 26K | 26K | 2K | 2K | 13K | 0 | 12K |
| Retained Earnings | -191.84M | -177.38M | -162.22M | -149.43M | -133.39M | -117.4M | -102.84M | -92.57M | -83.56M | -75.14M | -67.38M | 0 | -97.86M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -253K | 260K | 265K | 147K | 170K | 71K | 561K | -127K | -58K | 108K | -89K | -93.21M | -76K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |